KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nu Skin Enterprises (NUS) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Nu Skin Enterprises (NUS) over the last 17 years, with Q4 2025 value amounting to $131.3 million.

  • Nu Skin Enterprises' Cost of Revenue fell 2060.19% to $131.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $508.4 million, marking a year-over-year decrease of 2203.23%. This contributed to the annual value of $508.4 million for FY2025, which is 2203.23% down from last year.
  • As of Q4 2025, Nu Skin Enterprises' Cost of Revenue stood at $131.3 million, which was down 2060.19% from $130.3 million recorded in Q3 2025.
  • In the past 5 years, Nu Skin Enterprises' Cost of Revenue registered a high of $280.6 million during Q2 2021, and its lowest value of $118.5 million during Q1 2025.
  • Over the past 5 years, Nu Skin Enterprises' median Cost of Revenue value was $186.6 million (recorded in 2023), while the average stood at $194.1 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first skyrocketed by 3393.63% in 2021, then plummeted by 2363.96% in 2022.
  • Quarter analysis of 5 years shows Nu Skin Enterprises' Cost of Revenue stood at $263.3 million in 2021, then decreased by 23.64% to $201.0 million in 2022, then fell by 9.8% to $181.3 million in 2023, then decreased by 8.77% to $165.4 million in 2024, then decreased by 20.6% to $131.3 million in 2025.
  • Its Cost of Revenue stands at $131.3 million for Q4 2025, versus $130.3 million for Q3 2025 and $128.2 million for Q2 2025.